Financial Genius

Dear Readers,

Development is exciting, and it’s something all companies must undergo in order to exist. The nature of the development may be physical, technological, virtual, spiritual, ideological, or monetary. It is these developments that excite human beings, and excited human beings often offer their vote in direct response.

A vote may be positive, negative, or neutral. In the stock market, votes of excitement, fear, confidence, or a lack of confidence help make bulls and bears of positions. Because developments cause excitement, it would stand to reason that an investor savvy in predicting development is a wealthy investor indeed.

Currently, my portfolio is full of companies on the brink of development. eDoorways, Camelot Entertainment, and Cord Blood America are only a few. Recently, Cord Blood America (CBAI) built what may reasonably be the largest cryogenic research and storage facility in the world. The building will also act as their world headquarters.

eDoorways launches their online service platform tomorrow, and Camelot Entertainment has opened two offices — one in Europe, and one in the United States — in preparation for tons of upcoming film projects that they are scheduling as I write. These developments are exciting, and all three positions have been wildly active over the past month. For some, it feels as though these are now opportunities that have passed. For me, however, it was obvious long ago that these developments are only the beginning of a slew of opportunities to come.

Camelot Entertainment will release several hit titles in their massive barrage of developments. At the upcoming film festival, they’ll strike some connections that will take them, and their investors, far and wide. For eDoorways, their Austin, Texas launch will be followed by several modular releases that will add to their portfolio of service offerings, and their service offerings will go nationwide in the visible future. Cord Blood America will educate and expand on their and the world’s knowledge of cryogenics and stem cells.

These are all extremely exciting developments that are slated to occur in the foreseeable future. For anyone to say that these are opportunities long gone is a shortsighted opinion. As a savvy investor, it is often necessary to look at a larger picture and take the road bumps with a grain of salt. For businesses without development, business as usual is business of the past, and unfortunately for them, I look only to the future.

~A